← Open Payments lookup

EMILY MCCLANAHAN: Open Payments

NPI 1952066672 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,309 in 72 payments from 10 companies in 2025. Trend: 2023 $1,238 · 2024 $1,792 · 2025 $1,309

Food & beverage: $1,225Education: $84
CompanyPaymentsAmount
ABBVIE INC.22$337
Salix Pharmaceuticals, a division of Bausch Health US, LLC14$235
Janssen Biotech, Inc.8$229
Regeneron Healthcare Solutions, Inc.9$193
Takeda Pharmaceuticals U.S.A., Inc.10$155
Ardelyx, Inc.3$59
Lilly USA, LLC2$38
Ipsen Biopharmaceuticals, Inc1$25
Madrigal Pharmaceuticals1$20
Phathom Pharmaceuticals, Inc.2$16

Products named: XIFAXAN, TREMFYA, DUPIXENT, RINVOQ, LINZESS, ENTYVIO, IBSRELA, EOHILIA.

Industry payments across MO — which companies pay providers there.